Generali Asset Management SPA SGR Takes $1.95 Million Position in Humana Inc. (NYSE:HUM)

Generali Asset Management SPA SGR purchased a new stake in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 7,679 shares of the insurance provider’s stock, valued at approximately $1,948,000.

A number of other institutional investors have also recently made changes to their positions in the company. Kennondale Capital Management LLC purchased a new position in shares of Humana during the 4th quarter valued at $7,056,000. Retirement Planning Co of New England Inc. lifted its position in shares of Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after buying an additional 43 shares during the last quarter. William Blair Investment Management LLC lifted its position in shares of Humana by 13.7% during the 4th quarter. William Blair Investment Management LLC now owns 18,045 shares of the insurance provider’s stock valued at $4,578,000 after buying an additional 2,172 shares during the last quarter. Cibc World Markets Corp lifted its position in shares of Humana by 16.3% during the 4th quarter. Cibc World Markets Corp now owns 19,012 shares of the insurance provider’s stock valued at $4,824,000 after buying an additional 2,660 shares during the last quarter. Finally, Natixis Advisors LLC raised its stake in shares of Humana by 36.4% during the 4th quarter. Natixis Advisors LLC now owns 131,418 shares of the insurance provider’s stock valued at $33,342,000 after purchasing an additional 35,043 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Truist Financial boosted their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday. Nineteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.37% of the stock is currently owned by company insiders.

Humana Price Performance

Shares of Humana stock opened at $267.01 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $32.23 billion, a PE ratio of 26.84, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The business’s 50-day moving average price is $271.43 and its 200-day moving average price is $278.21. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.